Technical Analysis for PAND - Pandion Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Up | Up |
| Historical PAND trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Spinning Top | Other | 1.60% | |
| Outside Day | Range Expansion | 1.60% | |
| Wide Bands | Range Expansion | 1.60% | |
| Up 3 Days in a Row | Strength | 1.60% | |
| Narrow Range Bar | Range Contraction | 4.37% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 60 Minute Opening Range Breakout | 1 day ago | |
| 10 DMA Resistance | 1 day ago | |
| Down 3% | 1 day ago | |
| Down 2 % | 1 day ago | |
| Down 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Pandion Therapeutics is developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. Pandion’s TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform enables the company to create a pipeline of product candidates using immunomodulatory effector modules, with the ability to also combine an effector module with a tissue-targeted tether module in a bifunctional format. Pandion’s lead product candidate, PT101, is currently in a Phase 1a clinical trial.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Autoimmune Disease Autoimmunity Drug Design
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Autoimmune Disease Autoimmunity Drug Design
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.75 |
| 52 Week Low | 10.28 |
| Average Volume | 94,266 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 16.10 |
| 20-Day Moving Average | 17.08 |
| 10-Day Moving Average | 18.80 |
| Average True Range | 1.57 |
| ADX | 28.67 |
| +DI | 34.58 |
| -DI | 13.65 |
| Chandelier Exit (Long, 3 ATRs ) | 18.76 |
| Chandelier Exit (Short, 3 ATRs ) | 19.18 |
| Upper Bollinger Band | 21.08 |
| Lower Bollinger Band | 13.08 |
| Percent B (%b) | 0.75 |
| BandWidth | 46.82 |
| MACD Line | 0.83 |
| MACD Signal Line | 0.71 |
| MACD Histogram | 0.122 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.98 | ||||
| Resistance 3 (R3) | 20.80 | 20.00 | 20.67 | ||
| Resistance 2 (R2) | 20.00 | 19.52 | 20.09 | 20.56 | |
| Resistance 1 (R1) | 19.54 | 19.22 | 19.77 | 19.72 | 20.45 |
| Pivot Point | 18.74 | 18.74 | 18.85 | 18.83 | 18.74 |
| Support 1 (S1) | 18.28 | 18.26 | 18.51 | 18.46 | 17.73 |
| Support 2 (S2) | 17.48 | 17.96 | 17.57 | 17.62 | |
| Support 3 (S3) | 17.02 | 17.48 | 17.52 | ||
| Support 4 (S4) | 17.20 |
